Home Environmental Risks and Caregiver Awareness

June 11, 2026 updated by: Buğu Usanma Koban, Marmara University Pendik Training and Research Hospital

High Prevalence But Low Awareness of Environmental Risks in Home Care: A Cross-Sectional Study

This cross-sectional study aimed to assess home environmental risks and caregiver awareness among individuals receiving home healthcare services. It also examined factors associated with caregivers' awareness of these risks.

The main questions addressed in this study were:

  • How common were environmental risks in home care settings?
  • To what extent were caregivers aware of these risks?
  • Which factors were associated with caregiver awareness of home environmental risks? Participants receiving home healthcare services and their caregivers were evaluated during routine home visits. Data were collected through face-to-face interviews using a structured questionnaire and a home environmental risk checklist.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This cross-sectional study was conducted to evaluate home environmental risks and caregiver awareness among individuals receiving home healthcare services. Home care settings represent a complex care environment in which patient safety may be compromised by various environmental hazards. Despite the high prevalence of such risks, caregiver awareness and recognition remain limited, which may affect the safety and quality of care delivered in home settings.

The study population consisted of patients who applied to home healthcare services affiliated with a public hospital in Istanbul between January 20 and March 1, 2026, and their caregivers. Participants were evaluated during routine home visits.

Data were collected through face-to-face interviews using a structured questionnaire and a home environmental risk checklist developed based on existing home safety recommendations. The checklist was used to identify potential environmental hazards within the home setting. In addition, caregivers' awareness of these risks and their perceptions regarding the modifiability of risks were assessed.

Home environmental risks were categorized according to their level of modifiability as easy, moderate, or difficult, based on the type of intervention required. Caregiver-related factors, including prior information, caregiving experience, and sociodemographic characteristics, were also recorded.

The study aimed to describe the frequency of home environmental risks, assess the level of caregiver awareness, and examine factors associated with awareness. In addition, perceived barriers to risk mitigation, such as financial constraints and unsuitable housing conditions, were evaluated to better understand the structural challenges affecting home safety.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
326

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Maltepe
      • Istanbul, Maltepe, Turkey (Türkiye)
        • Marmara University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consisted of caregivers providing care to individuals receiving home healthcare services during the study period. Participants were identified during routine home visits conducted by home healthcare teams and were included based on their role as primary providers of care within the home setting.

Description

Inclusion Criteria:

  • Caregivers of individuals receiving home healthcare services during the study period
  • Caregivers who were present during routine home visits
  • Caregivers who agreed to participate and provided informed responses
  • Caregivers without communication barriers (e.g., language-related difficulties)

Exclusion Criteria:

  • Caregivers in households where an acute medical condition requiring urgent intervention was present at the time of the visit
  • Caregivers who declined to participate or were unable to complete the assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Caregivers in Home Healthcare Settings
Caregivers of individuals receiving home healthcare services, providing information on home environmental risks and awareness during routine home visits.
Other: Observation
No intervention was administered. This observational study involved the assessment of home environmental risks and caregiver awareness during routine home healthcare visits.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Presence of home environmental risks
Time Frame: baseline
The proportion of households with at least one identified environmental risk, including fall-related hazards (slippery floors, inadequate lighting, clutter), risks related to medical device use, and structural safety problems within the home environment, assessed using a structured home safety checklist.
baseline

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Caregiver awareness of home environmental risks
Time Frame: baseline
The proportion of caregivers who correctly reported the presence of environmental risks in the home, based on comparison with risks identified through the structured home safety checklist.
baseline
Barriers to addressing home environmental risks
Time Frame: baseline
Caregiver-reported barriers to addressing environmental risks in the home, including financial constraints, unsuitable housing conditions, and other perceived limitations.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Marmara University Pendik Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 20, 2026

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 5, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 11, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 12, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 11, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 09.2026.26-0025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy considerations and the nature of the data collected in home care settings.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Home Health Care

Clinical Trials on Observation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings